Canada Markets closed

SOPHiA GENETICS SA (SOPH)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
4.9700+0.3400 (+7.34%)
At close: 04:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close4.6300
Open4.7000
Bid3.4000 x 900
Ask5.2000 x 1100
Day's Range4.4000 - 4.9900
52 Week Range1.6850 - 8.0400
Volume83,944
Avg. Volume133,772
Market Cap319.128M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Business Wire

    Acutis Diagnostics Leverages SOPHiA GENETICS Technology to Create New Next Generation Sequencing Test

    BOSTON & LAUSANNE, Switzerland, March 28, 2023--SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and a leader in data-driven medicine, today announced that Acutis Diagnostics, a specialized medical laboratory, will use SOPHiA DDM™ to develop a new genomic assay. This new next-generation sequencing (NGS) test will build on Acutis Diagnostics’ track record of approved lab-developed tests that support clinical trials, cancer research and treatment.

  • Business Wire

    SOPHiA GENETICS and Agilent Partner on Comprehensive Solution for Cancer Analysis

    BOSTON & LAUSANNE, Switzerland, March 14, 2023--SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and the leader in data-driven medicine, is partnering with Agilent to offer a comprehensive solution for cancer analysis.

  • Business Wire

    SOPHiA GENETICS Reports Fourth Quarter and Year End 2022 Financial Results

    BOSTON & LAUSANNE, Switzerland, March 07, 2023--SOPHiA GENETICS SA (Nasdaq: SOPH), a cloud-native software company in the healthcare space, today announced financial results for its fourth quarter and full fiscal year ended December 31, 2022.